pdva (LimFlow GmbH)
Structured Review
Pdva, supplied by LimFlow GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdva+system/pdva/pm40132745-22-16-36
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: PROMISE I: Early feasibility study of the LimFlow System for percutaneous deep vein arterialization in no-option chronic limb-threatening ischemia: 12-month results. Article Snippet: 6 Take home Message: The Article Title: Endovascular Interventions for Peripheral Artery Disease: A Contemporary Review. Article Snippet: Purpose of Review Peripheral artery disease (PAD) is an increasingly prevalent but frequently underdiagnosed condition that can be associated with high rates of morbidity and mortality.. While an initial noninvasive approach is the cornerstone of management, revascularization is often pursued for patients with treatment-refractory claudication or chronic limbthreatening ischemia (CLTI).. In this review, we discuss the current state of endovascular interventions for PAD and explore the many new emerging technologies. |

